Hemozoin-induced immunomodulation and prostate carcinogenesis: mechanisms and implications
-
By
-
Abimbola D. Akinyosoye
-
Solomon O. Rotimi
-
Olutola E. Olasehinde
-
Gbolahan O. Oduselu
-
Solomon U. Oranusi
-
Olayemi O. Akinnola
-
May 4, 2026
-
Clinical Scorecard: Immunomodulatory Effects of Hemozoin and Their Role in Prostate Cancer Development: Mechanisms and Consequences
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Men, particularly aged 40 and above in malaria endemic regions. |
| Care Setting | |
Key Highlights
- Add citations for epidemiological links and mechanisms.
Guideline-Based Recommendations
Diagnosis
Management
- Investigate specific immunomodulatory therapies such as checkpoint inhibitors or cytokine therapies targeting hemozoin-related pathways.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Focus on managing inflammation through NSAIDs or corticosteroids and immune modulation via targeted therapies.
Clinical Best Practices
- Integrate infectious disease history by using standardized questionnaires and screening tools.
References
